EGFR and cancer: Additionally, Zhang et al. found that HOXA3 can serve as an apoptosis-suppressor for cancer development through regulation of apoptosis-related factors (Bcl-2 andcaspase 3) and the activation of the EGFR/Ras/Raf/MEK/ERK pathway [36].